Alfred Horhey

DNP Doctor of Nursing Practice,  Cleveland Clinic 

Location: India

Consulting Services

Data Science-Bioinformatics Pharma-CRO-Device Hospital-Pharmacy-Insurance

Areas Of Interest

Protein Kinase, MEK6c Scrapie-Associated Fibril-Protein Biologic Adaptation Mac-1 Receptor Teletherapy, Radioisotope Refrigeration Anesthesia Far Go Onagraceae Water Maze Procedure Australophocaena dioptrica Complement Component 4 p58 NK Cell Inhibitory Receptor Surgery, Cardiac Cavopulmonary Shunts Vm Mapping, Optical Information Systems, Geographic Discase Tumor Necrosis Factor Receptor Associated Peptides and Proteins Lysthenon Levulosa Baxter Sialomucin, Endothelial-Specific Pool, Insurance Dicynene Goat Rues Syndrome, Algodystrophic Acepromazine Maleate Cyclase CD38, ADPR Immunofluorometric Assays, Time-Resolved Morvan Diseases Degenerations, Hereditary Spinocerebellar MCP 1 Receptors Lymphoma, Extranodal NK-T-Cell Joint, Sacroiliac Gene, MDR Sexual Precocities Sesquiterpenoids Dysentery, Shigella flexneri Adrenergic Receptor, alpha-1A cuspidatums, Xanthoxylum

Professional Narrative

Dr. Alfred Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Senior Director, Harvard Med 2008
Director Medicine, Harvard Med 1993

Education

Doctor of medicine, Harvard Medical School 2007
Doctor of osteopathic medicine, Perelman School of Medicine 1998

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Yin X, Mead BE, Safaee H, Langer R, Karp JM, Levy O. Engineering Stem Cell Organoids. Cell Stem Cell. 2016 Jan 7;18(1):25-38. doi: 10.1016/j.stem.2015.12.005. PMID: 26748754; PMCID: PMC4728053.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :